Carnosine's effect on amyloid fibril formation and induced cytotoxicity of lysozyme

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Wu, Josephine W ^a   Liu, Kuan Nan ^b   How, Su Chun ^b   Chen, Wei An ^b   Lai, Chia Min ^b   Liu, Hwai Shen ^b   Hu, Chaur Jong ^c   Wang, Steven S S ^b  

^a CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CARNOSINE; LYSOZYME;

ANTIFIBRILLOGENSIS EFFECT; APOPTOSIS; ARTICLE; CELL STRAIN; CELL STRAIN SH SY5Y; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; MOLECULAR DOCKING; NERVE CELL; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; PROTEIN AGGREGATION; PROTEIN BINDING;

AMYLOID; ANIMALS; APOPTOSIS; AVIAN PROTEINS; BINDING SITES; CARNOSINE; CELL LINE, TUMOR; CHICKENS; HUMANS; MOLECULAR DOCKING SIMULATION; MURAMIDASE; NEURONS; PROTEIN BINDING;

EID: 84892379754     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081982     Document Type: Article

References (150)

1. Dobson CM (2004) Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 15: 3-16.
2. Wang SSS, Good TA (2005) An overview of Alzheimer's disease. Journal of the Chinese Institute of Chemical Engineers 36: 533-559.
3. Liberski PP, Sikorska B, Hauw JJ, Kopp N, Streichenberger N, et al. (2010) Ultrastructural Characteristics (or Evaluation) of Creutzfeldt-Jakob Disease and Other Human Transmissible Spongiform Encephalopathies or Prion Diseases. Ultrastructural Pathology 34: 351-361.
4. Kell DB (2010) Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Archives of Toxicology 84: 825-889.
5. Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl: S10-17.
6. Uversky VN, Fink AL (2004) Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta 1698: 131-153.
7. Chiti F, Dobson CM (2009) Amyloid formation by globular proteins under native conditions. Nat Chem Biol 5: 15-22.
8. Ferrao-Gonzales AD, Souto SO, Silva JL, Foguel D (2000) The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state. Proc Natl Acad Sci U S A 97: 6445-6450.
9. Wang SSS, Liu KN, Han TC (2010) Amyloid fibrillation and cytotoxicity of insulin are inhibited by the amphiphilic surfactants. Biochimica Et Biophysica Acta-Molecular Basis of Disease 1802: 519-530.
10. Naeem A, Khan T, Muzaffar M, Ahmad S, Saleemuddin M (2011) A Partially Folded State of Ovalbumin at Low pH Tends to Aggregate. Cell Biochemistry and Biophysics 59: 29-38.
11. Zhang C, Jackson AP, Zhang ZR, Han Y, Yu S, et al. (2010) Amyloid-Like Aggregates of the Yeast Prion Protein Ure2 Enter Vertebrate Cells by Specific Endocytotic Pathways and Induce Apoptosis. Plos One 5: -.
12. De Meulenaer B, Kerkaert B, Mestdagh F (2010) Detection of hen's egg white lysozyme in food: Comparison between a sensitive HPLC and a commercial ELISA method. Food Chemistry 120: 580-584.
13. Proctor VA, Cunningham FE (1988) The Chemistry of Lysozyme and Its Use as a Food Preservative and a Pharmaceutical. Crc Critical Reviews in Food Science and Nutrition 26: 359-395.
14. Bolin KA, Millhauser GL (1999) alpha and 3(10): The split personality of polypeptide helices. Accounts of Chemical Research 32: 1027-1033.
15. Vaney MC, Maignan S, RiesKautt M, Ducruix A (1996) High-resolution structure (1.33 angstrom) of a HEW lysozyme tetragonal crystal grown in the APCF apparatus. Data and structural comparison with a crystal grown under microgravity from SpaceHab-01 mission. Acta Crystallographica Section D-Biological Crystallography 52: 505-517.
16. Morozova-Roche LA, Zurdo J, Spencer A, Noppe W, Receveur V, et al. (2000) Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. Journal of Structural Biology 130: 339-351.
17. Krebs MRH, Wilkins DK, Chung EW, Pitkeathly MC, Chamberlain AK, et al. (2000) Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. Journal of Molecular Biology 300: 541-549.
18. Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, et al. (1993) Human Lysozyme Gene-Mutations Cause Hereditary Systemic Amyloidosis. Nature 362: 553-557.
19. Arnaudov LN, de Vries R (2005) Thermally induced fibrillar aggregation of hen egg white lysozyme. Biophysical Journal 88: 515-526.
20. Goda S, Takano K, Yamagata Y, Nagata R, Akutsu H, et al. (2000) Amyloid protofilament formation of hen egg lysozyme in highly concentrated ethanol solution. Protein Science 9: 369-375.
21. Vernaglia BA, Huang J, Clark ED (2004) Guanidine hydrochloride can induce amyloid fibril formation from hen egg-white lysozyme. Biomacromolecules 5: 1362-1370.
22. Wang SSS, Liu KN, Lee WH (2009) Effect of curcumin on the amyloid fibrillogenesis of hen egg-white lysozyme. Biophysical Chemistry 144: 78-87.
23. Rafii MS, Aisen PS (2009) Recent developments in Alzheimer's disease therapeutics. BMC Med 7: 7.
24. Jakob-Roetne R, Jacobsen H (2009) Alzheimer's disease: from pathology to therapeutic approaches. Angew Chem Int Ed 48: 3030-3059.
25. Vardy ERLC, Catto AJ, Hooper NM (2005) Proteolytic mechanisms in amyloid- b metabolism: therapeutic implications for Alzheimer's disease. Trends Mol Med 11: 464-472.
26. Lim GP, Calon F, Morihara T, Yang FS, Teter B, et al. (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. Journal of Neuroscience 25: 3032-3040.
27. Yang FS, Lim GP, Begum AN, Ubeda OJ, Simmons MR, et al. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. Journal of Biological Chemistry 280: 5892-5901.
28. Wang SS, Hung YT, Wen WS, Lin KC, Chen GY (2011) Exploring the inhibitory activity of short-chain phospholipids against amyloid fibrillogenesis of hen egg-white lysozyme. Biochim Biophys Acta 1811: 301-313.
29. Boldyrev AA (2000) Problems and perspectives in studying the biological role of carnosine. Biochemistry (Mosc) 65: 751-756.
30. Abe H (2000) Role of histidine-related compounds as intracellular proton buffering constituents in vertebrate muscle. Biochemistry-Moscow 65: 757-765.
31. Bauer K (2005) Carnosine and homocarnosine, the forgotten, enigmatic peptides of the brain. Neurochemical Research 30: 1339-1345.
32. Boldyrev A, Bulygina E, Leinsoo T, Petrushanko I, Tsubone S, et al. (2004) Protection of neuronal cells against reactive oxygen species by carnosine and related compounds. Comparative Biochemistry and Physiology B-Biochemistry & Molecular Biology 137: 81-88.
33. Pegova A, Abe H, Boldyrev A (2000) Hydrolysis of carnosine and related compounds by mammalian carnosinases. Comparative Biochemistry and Physiology B-Biochemistry & Molecular Biology 127: 443-446.
34. Teufel M, Saudek V, Ledig JP, Bernhardt A, Boularand S, et al. (2003) Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. Journal of Biological Chemistry 278: 6521-6531.
35. Hipkiss AR, Brownson C (2000) Carnosine reacts with protein carbonyl groups: another possible role for the anti-ageing peptide? Biogerontology 1: 217-223.
36. McFarland GA, Holliday R (1994) Retardation of the Senescence of Cultured Human-Diploid Fibroblasts by Carnosine. Experimental Cell Research 212: 167-175.
37. McFarland GA, Holliday R (1999) Further evidence for the rejuvenating effects of the dipeptide L-carnosine on cultured human diploid fibroblasts. Experimental Gerontology 34: 35-45.
38. Babizhayev MA (2011) Designation of imidazole-containing dipeptides as pharmacological chaperones. Hum Exp Toxicol 30: 736-761.
39. Hipkiss AR (2011) Energy metabolism, proteotoxic stress and age-related dysfunction - protection by carnosine. Mol Aspects Med 32: 267-278.
40. Seidler NW, Yeargans GS, Morgan TG (2004) Carnosine disaggregates glycated alpha-crystallin: an in vitro study. Arch Biochem Biophys 427: 110-115.
41. Attanasio F, Cataldo S, Fisichella S, Nicoletti S, Nicoletti VG, et al. (2009) Protective Effects of L- and D-Carnosine on alpha-Crystallin Amyloid Fibril Formation: Implications for Cataract Disease. Biochemistry 48: 6522-6531.
42. Corona C, Frazzini V, Silvestri E, Lattanzio R, La Sorda R, et al. (2011) Effects of Dietary Supplementation of Carnosine on Mitochondrial Dysfunction, Amyloid Pathology, and Cognitive Deficits in 3xTg-AD Mice. Plos One 6.
43. Attanasio F, Convertino M, Magno A, Caflisch A, Corazza A, et al. (2013) Carnosine Inhibits A beta 42 Aggregation by Perturbing the H-Bond Network in and around the Central Hydrophobic Cluster. Chembiochem 14: 583-592.
44. Aloisi A, Barca A, Romano A, Guerrieri S, Storelli C, et al. (2013) Anti-aggregating effect of the naturally occurring dipeptide carnosine on abeta1-42 fibril formation. Plos One 8: e68159.
45. Preston JE, Hipkiss AR, Himsworth DT, Romero IA, Abbott JN (1998) Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine. Neurosci Lett 242: 105-108.
46. Fu QL, Dai HB, Hu WW, Fan YY, Shen Y, et al. (2008) Carnosine protects against A beta 42-induced neurotoxicity in differentiated rat PC12 cells. Cellular and Molecular Neurobiology 28: 307-316.
47. Li QQ, Sun YP, Ruan CP, Xu XY, Ge JH, et al. (2011) Cellular prion protein promotes glucose uptake through the Fyn-HIF-2a-Glut1 pathway to support colorectal cancer survival. Cancer Sci 102: 400-406.
48. Lowik DWPM, Meijer JT, Roeters M, Viola V, Vriend G, et al. (2007) Stabilization of peptide fibrils by hydrophobic interaction. Langmuir 23: 2058-2063.
49. Kato A, Harada A, Azakami H (2008) Amyloid fibril formation of hen lysozyme depends on the instability of the C-helix (88-99). Bioscience Biotechnology and Biochemistry 72: 1523-1530.
50. Kroes-Nijboer A, Venema P, Bouman J, van der Linden E (2011) Influence of Protein Hydrolysis on the Growth Kinetics of beta-Ig Fibrils. Langmuir 27: 5753-5761.
51. Nielsen L, Khurana R, Coats A, Frokjaer S, Brange J, et al. (2001) Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40: 6036-6046.
52. Darghal N, Garnier-Suillerot A, Salerno M (2006) Mechanism of thioflavin T accumulation inside cells overexpressing P-glycoprotein or multidrug resistance-associated protein: Role of lipophilicity and positive charge. Biochemical and Biophysical Research Communications 343: 623-629.
53. Klunk WE, Jacob RF, Mason RP (1999) Quantifying amyloid by Congo red spectral shift assay. Amyloid, Prions, and Other Protein Aggregates 309: 285-305.
54. Whitmore L, Wallace BA (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Research 32: W668-W673.
55. Whitmore L, Wallace BA (2008) Protein secondary structure analyses from circular dichroism spectroscopy: Methods and reference databases. Biopolymers 89: 392-400.
56. Brown MB, Miller JN, Seare NJ (1995) An Investigation of the Use of Nile-Red as a Long-Wavelength Fluorescent-Probe for the Study of Alpha(1)-Acid Glycoprotein-Drug Interactions. Journal of Pharmaceutical and Biomedical Analysis 13: 1011-1017.
57. Cser A, Nagy K, Biczok L (2002) Fluorescence lifetime of Nile Red as a probe for the hydrogen bonding strength with its microenvironment. Chemical Physics Letters 360: 473-478.
58. Conchillo-Sole O, de Groot NS, Aviles FX, Vendrell J, Daura X, et al. (2007) AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics 8: 65.
59. Frousios KK, Iconomidou VA, Karletidi CM, Hamodrakas SJ (2009) Amyloidogenic determinants are usually not buried. BMC Struct Biol 9: 44.
60. Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 22: 1302-1306.
61. Hamodrakas SJ, Liappa C, Iconomidou VA (2007) Consensus prediction of amyloidogenic determinants in amyloid fibril-forming proteins. Int J Biol Macromol 41: 295-300.
62. Lopez de la Paz M, Serrano L (2004) Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci U S A 101: 87-92.
63. Galzitskaya OV, Garbuzynskiy SO, Lobanov MY (2006) Prediction of amyloidogenic and disordered regions in protein chains. PLoS Comput Biol 2: e177.
64. Zhang Z, Chen H, Lai L (2007) Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential. Bioinformatics 23: 2218-2225.
65. Wu G, Robertson DH, Brooks CL 3rd, Vieth M (2003) Detailed analysis of grid-based molecular docking: A case study of CDOCKER-A CHARMmbased MD docking algorithm. J Comput Chem 24: 1549-1562.
66. Brooks BRB, R. E.; . Olafson, B. D.; . States, D. J.; . Swaminathan, S. (1983) CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 4: 187.
67. Pollack SJ, Sadler IIJ, Hawtin SR, Tailor VJ, Shearman MS (1995) Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of [beta]-amyloid in rat PC12 cells. Neuroscience Letters 184: 113-116.
68. Vassar PS, Culling CFA (1959) Fluorescent Stains, with Special Reference to Amyloid and Connective Tissues. Archives of Pathology 68: 487-498.
69. Ladewig P (1945) Double-Refringence of the Amyloid-Congo-Red-Complex in Histological Sections. Nature 156: 81-82.
70. Turnell WG, Finch JT (1992) Binding of the Dye Congo Red to the Amyloid Protein Pig Insulin Reveals a Novel Homology Amongst Amyloid-Forming Peptide Sequences. Journal of Molecular Biology 227: 1205-1223.
71. Geddes CD, Lakowicz JR, Coutinho PJG (2009) Photophysics and Biophysical Applications of Benzo〈i〉a〈i〉phenoxazine Type Fluorophores. Reviews in Fluorescence 2007: Springer New York. pp. 335-362.
72. Ghanta J, Shen CL, Kiessling LL, Murphy RM (1996) A strategy for designing inhibitors of beta-amyloid toxicity. Journal of Biological Chemistry 271: 29525-29528.
73. Terry AV, Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development. Journal of Pharmacology and Experimental Therapeutics 306: 821-827.
74. Contestabile A (2011) The history of the cholinergic hypothesis. Behavioural Brain Research 221: 334-340.
75. Wenk GL (2003) Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 64 Suppl 9: 7-10.
76. Williams DR (2006) Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Internal Medicine Journal 36: 652-660.
77. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, et al. (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21: 383-421.
78. Zotova E, Nicoll JAR, Kalaria R, Holmes C, Boche D (2010) Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimers Research & Therapy 2.
79. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23: 134-147.
80. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, et al. (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. New England Journal of Medicine 336: 1216-1222.
81. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nature Reviews Molecular Cell Biology 8: 101-112.
82. Hardy J, Selkoe DJ (2002) Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297: 353-356.
83. Sharp JS, Forrest JA, Jones RAL (2002) Surface Denaturation and Amyloid Fibril Formation of Insulin at Model Lipid2Water Interfaces. Biochemistry 41: 15810-15819.
84. Hung YT, Lin MS, Chen WY, Wang SS (2010) Investigating the effects of sodium dodecyl sulfate on the aggregative behavior of hen egg-white lysozyme at acidic pH. Colloids Surf B Biointerfaces 81: 141-151.
85. Harada A, Azakami H, Kato A (2008) Amyloid fibril formation of hen lysozyme depends on the instability of the C-helix (88-99). Bioscience Biotechnology and Biochemistry 72: 1523-1530.
86. Gharibyan AL, Zamotin V, Yanamandra K, Moskaleva OS, Margulis BA, et al. (2007) Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathways. Journal of Molecular Biology 365: 1337-1349.
87. Chaudhary N, Nagaraj R (2009) Hen lysozyme amyloid fibrils induce aggregation of erythrocytes and lipid vesicles. Molecular and Cellular Biochemistry 328: 209-215.
88. Armen RS, Daggett V (2005) Characterization of two distinct beta(2)-microglobulin unfolding intermediates that may lead to amyloid fibrils of different morphology. Biochemistry 44: 16098-16107.
89. Chiti F, Mangione P, Andreola A, Giorgetti S, Stefani M, et al. (2001) Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin. Journal of Molecular Biology 307: 379-391.
90. Colon W, Lai ZH, McCutchen SL, Miroy GJ, Strang C, et al. (1996) FAP mutations destabilize transthyretin facilitating conformational changes required for amyloid formation. Nature and Origin of Amyloid Fibrils 199: 228-242.
91. Fezoui Y, Teplow DB (2002) Kinetic studies of amyloid beta-protein fibril assembly - Differential effects of alpha-helix stabilization. Journal of Biological Chemistry 277: 36948-36954.
92. Litvinovich SV, Brew SA, Aota S, Akiyama SK, Haudenschild C, et al. (1998) Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. Journal of Molecular Biology 280: 245-258.
93. Wiseman RL, Powers ET, Kelly JW (2005) Partitioning conformational intermediates between competing refolding and aggregation pathways: Insights into transthyretin amyloid disease. Biochemistry 44: 16612-16623.
94. Yamamoto S, Hasegawa K, Yamaguchi I, Tsutsumi S, Kardos J, et al. (2004) Low concentrations of sodium dodecyl sulfate induce the extension of beta(2)-microglobulin-related amyloid fibrils at a neutral pH. Biochemistry 43: 11075-11082.
95. Canale C, Torrassa S, Rispoli P, Relini A, Rolandi R, et al. (2006) Natively folded HypF-N and its early amyloid aggregates interact with phospholipid monolayers and destabilize supported phospholipid bilayers. Biophysical Journal 91: 4575-4588.
96. Wang W (2005) Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm 289: 1-30.
97. Walsh DM, Selkoe DJ (2004) Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 11: 213-228.
98. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112.
99. Khlistunova I, Biernat J, Wang YP, Pickhardt M, von Bergen M, et al. (2006) Inducible expression of tau repeat domain in cell models of tauopathy - Aggregation is toxic to cells but can be reversed by inhibitor drugs. Journal of Biological Chemistry 281: 1205-1214.
100. Roberson ED, Scearce-Levie K, Palop JJ, Yan FR, Cheng IH, et al. (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316: 750-754.
101. Defelice FG, Ferreira ST (2002) Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease. An Acad Bras Cienc 74: 265-284.
102. Estrada LD, Soto C (2007) Disrupting beta-amyloid aggregation for Alzheimer disease treatment. Curr Top Med Chem 7: 115-126.
103. Porat Y, Abramowitz A, Gazit E (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67: 27-37.
104. Vieira MNN, Figueroa-Villar JD, Meirelles MNL, Ferreira ST, De Felice FG (2006) Small molecule inhibitors of lysozyme amyloid aggregation. Cell Biochemistry and Biophysics 44: 549-553.
105. Gazova Z, Bellova A, Daxnerova Z, Imrich J, Kristian P, et al. (2008) Acridine derivatives inhibit lysozyme aggregation. European Biophysics Journal with Biophysics Letters 37: 1261-1270.
106. Pallitto MM, Ghanta J, Heinzelman P, Kiessling LL, Murphy RM (1999) Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity. Biochemistry 38: 3570-3578.
107. Soto C, Sigurdsson EM, Morelli L, Kumar RA, Castano EM, et al. (1998) Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med 4: 822-826.
108. Hetenyi C, Szabo Z, Klement E, Datki Z, Kortvelyesi T, et al. (2002) Pentapeptide amides interfere with the aggregation of beta-amyloid peptide of Alzheimer's disease. Biochem Biophys Res Commun 292: 931-936.
109. Lee S, Carson K, Rice-Ficht A, Good T (2005) Hsp20, a novel {alpha}- crystallin, prevents A{beta} fibril formation and toxicity. Protein Science 14: 593-601.
110. Santhoshkumar P, Sharma KK (2004) Inhibition of amyloid fibrillogenesis and toxicity by a peptide chaperone. Molecular and Cellular Biochemistry 267: 147-155.
111. Taniguchi S, Suzuki N, Masuda M, Hisanaga S, Iwatsubo T, et al. (2005) Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. Journal of Biological Chemistry 280: 7614-7623.
112. Klunk WE, Debnath ML, Koros AM, Pettegrew JW (1998) Chrysamine-G, a lipophilic analogue of Congo red, inhibits A beta-induced toxicity in PC12 cells. Life Sci 63: 1807-1814.
113. Howlett DR, Perry AE, Godfrey F, Swatton JE, Jennings KH, et al. (1999) Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans. Biochemical Journal 340: 283-289.
114. Pickhardt A, Biemat J, Khlistunova I, Wang YP, Gazova Z, et al. (2007) Nphenylamine derivatives as aggregation inhibitors in cell models of Tauopathy. Current Alzheimer Research 4: 397-402.
115. De Felice FG, Vieira MNN, Meirelles MNL, Morozova-Roche LA, Dobson CM, et al. (2004) Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure. Faseb Journal 18: 1099-1101.
116. Hitzig BM, Johnson DC, Kazemi H, Burt CT (1987) Differences in Temperature-Induced Changes in the Pk of Imidazole and the Imidazole Moiety of Carnosine in Binary Buffer Solutions. Federation Proceedings 46: 1103-1103.
117. Singh SR, Carreiro ST, Chu J, Prasanna G, Niesman MR, et al. (2009) LCarnosine: multifunctional dipeptide buffer for sustained-duration topical ophthalmic formulations. Journal of Pharmacy and Pharmacology 61: 733-742.
118. Torreggiani A, Fini G, Bottura G (2001) Effect of transition metal binding on the tautomeric equilibrium of the carnosine imidazolic ring. Journal of Molecular Structure 565: 341-346.
119. Baran EJ (2000) Metal complexes of carnosine. Biochemistry-Moscow 65: 789-797.
120. Lenz GR, Martell AE (1964) Metal Complexes of Carnosine. Biochemistry 3: 750-&.
121. Hipkiss AR (2006) Would Carnosine or a Carnivorous Diet Help Suppress Aging and Associated Pathologies? Understanding and Modulating Aging 1067: 369-374.
122. Stuerenburg HJ (2000) The roles of carnosine in aging of skeletal muscle and in neuromuscular diseases. Biochemistry-Moscow 65: 862-865.
123. Fu HY, Katsumura Y, Lin MZ, Muroya Y, Hata K, et al. (2009) Free radical scavenging and radioprotective effects of carnosine and anserine. Radiation Physics and Chemistry 78: 1192-1197.
124. Nakagawa K, Ueno A, Nishikawa Y (2006) Interactions between carnosine and captopril on free radical scavenging activity and angiotensin-converting enzyme activity in vitro. Yakugaku Zasshi-Journal of the Pharmaceutical Society of Japan 126: 37-42.
125. Yuneva MO, Bulygina ER, Gallant SC, Kramarenko GG, Stvolinsky SL, et al. (1999) Effect of Carnosine on Age-Induced Changes in Senescence-Accelerated Mice. Journal of Anti-Aging Medicine 2: 337-342.
126. Hipkiss AR (1998) Carnosine, a protective, anti-ageing peptide? Int J Biochem Cell Biol 30: 863-868.
127. Rashid I, van Reyk DM, Davies MJ (2007) Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro. Febs Letters 581: 1067-1070.
128. Alhamdani MSS, Al-Azzawie HF, Abbas FKH (2007) Decreased formation of advanced glycation end-products in peritoneal fluid by carnosine and related peptides. Peritoneal Dialysis International 27: 86-89.
129. Yan H, Harding JJ (2005) Carnosine protects against the inactivation of esterase induced by glycation and a steroid. Biochimica Et Biophysica Acta-Molecular Basis of Disease 1741: 120-126.
130. Gugliucci A, Smith ME, Menini T (2002) Carnosine in physiological concentrations inhibits advanced glycation of histones by reactive trioses methylgyoxal and glyceraldehyde. Diabetes 51: A513-A513.
131. Yeargans GS, Seidler NW (2003) Carnosine promotes the heat denaturation of glycated protein. Biochem Biophys Res Commun 300: 75-80.
132. Seidler NW (2000) Carnosine prevents the glycation-induced changes in electrophoretic mobility of aspartate aminotransferase. J Biochem Mol Toxicol 14: 215-220.
133. Babizhayev MA, Deyev AI, Yermakova VN, Semiletov YA, Davydova NG, et al. (2002) Efficacy of N-acetylcarnosine in the treatment of cataracts. Drugs R D 3: 87-103.
134. Rabbani G, Ahmad E, Zaidi N, Fatima S, Khan RH (2012) pH-Induced molten globule state of Rhizopus niveus lipase is more resistant against thermal and chemical denaturation than its native state. Cell Biochem Biophys 62: 487-499.
135. Rabbani G, Ahmad E, Zaidi N, Khan RH (2011) pH-dependent conformational transitions in conalbumin (ovotransferrin), a metalloproteinase from hen egg white. Cell Biochem Biophys 61: 551-560.
136. Sen P, Ahmad B, Rabbani G, Khan RH (2010) 2,2,2-Trifluroethanol induces simultaneous increase in alpha-helicity and aggregation in alkaline unfolded state of bovine serum albumin. Int J Biol Macromol 46: 250-254.
137. Wang SSS, Chen PH, Hung YT (2006) Effects of p-benzoquinone and melatonin on amyloid fibrillogenesis of hen egg-white lysozyme. Journal of Molecular Catalysis B-Enzymatic 43: 49-57.
138. Sunde M, Blake CCF (1998) From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Quarterly Reviews of Biophysics 31: 1-39.
139. Nordstedt C, Naslund J, Tjernberg LO, Karlstrom AR, Thyberg J, et al. (1994) The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils. Journal of Biological Chemistry 269: 30773-30776.
140. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annual Review of Biochemistry 75: 333-366.
141. Esteras-Chopo A, Serrano L, de la Paz ML (2005) The amyloid stretch hypothesis: Recruiting proteins toward the dark side. Proceedings of the National Academy of Sciences of the United States of America 102: 16672-16677.
142. Hamodrakas SJ (2011) Protein aggregation and amyloid fibril formation prediction software from primary sequence: towards controlling the formation of bacterial inclusion bodies. Febs Journal 278: 2428-2435.
143. Rousseau F, Schymkowitz J, Serrano L (2006) Protein aggregation and amyloidosis: confusion of the kinds? Current Opinion in Structural Biology 16: 118-126.
144. de Groot NS, Pallares I, Aviles FX, Vendrell J, Ventura S (2005) Prediction of "hot spots" of aggregation in disease-linked polypeptides. Bmc Structural Biology 5.
145. Magalhaes A, Maigret B, Hoflack J, Gomes JANF, Scheraga HA (1994) Contribution of Unusual Arginine-Arginine Short-Range Interactions to Stabilization and Recognition in Proteins. Journal of Protein Chemistry 13: 195-215.
146. Vondrasek J, Mason PE, Heyda J, Collins KD, Jungwirth P (2009) The Molecular Origin of Like-Charge Arginine-Arginine Pairing in Water. Journal of Physical Chemistry B 113: 9041-9045.
147. Heyda J, Mason PE, Jungwirth P (2010) Attractive Interactions between Side Chains of Histidine-Histidine and Histidine-Arginine-Based Cationic Dipeptides in Water. Journal of Physical Chemistry B 114: 8744-8749.
148. Demuro A, Mina E, Kayed R, Milton SC, Parker I, et al. (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. Journal of Biological Chemistry 280: 17294-17300.
149. Preston JE, Hipkiss AR, Himsworth DTJ, Romero IA, Abbott JN (1998) Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine. Neuroscience Letters 242: 105-108.
150. Babizhayev MA (2012) Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform. Drug Test Anal 4: 468-485.